The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions.

The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions.
复制标题

动物模型在评估基于细胞的神经系统疾病干预人体试验的合理安全性和有效性方面的作用。

DOI:
10.1038/jcbfm.2008.98
复制
发表时间:
2009-01
期刊:
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

再生医学的进展似乎有可能产生使用人类细胞作为治疗剂的神经系统疾病的新疗法;至少一项此类干预的试验已经在进行中。基于细胞的神经系统疾病干预(cbi - nc)的发展可能包括使用动物作为有兴趣条件的人类模型的临床前研究。本文探讨了预测效度的挑战和动物模型在开发CBI-NCs中的适当作用。尽管存在局限性,动物模型仍然是并将继续是在首次人体临床试验之前收集数据的重要工具。本文的目的是为观察动物模型在cbi - nc背景下的作用提供一个现实的视角,并为在这一具有挑战性的领域中前进提供建议。
Progress in regenerative medicine seems likely to produce new treatments for neurologic conditions that use human cells as therapeutic agents; at least one trial for such an intervention is already under way. The development of cell-based interventions for neurologic conditions (CBI-NCs) will likely include preclinical studies using animals as models for humans with conditions of interest. This paper explores predictive validity challenges and the proper role for animal models in developing CBI-NCs. In spite of limitations, animal models are and will remain an essential tool for gathering data in advance of first-in-human clinical trials. The goal of this paper is to provide a realistic lens for viewing the role of animal models in the context of CBI-NCs and to provide recommendations for moving forward through this challenging terrain.
DOI: 10.1007/978-0-387-74904-4_1
发表时间: 2008-01-01
期刊: RECENT ADVANCES IN RETINAL DEGENERATION
影响因子: --
作者:
Adler, Ruben
通讯作者: Adler, Ruben
DOI: 10.1602/neurorx.1.1.36
发表时间: 2004-01-01
期刊: NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics
影响因子: --
作者:
Cheng, Yu Dennis;Al-Khoury, Lama;Zivin, Justin A
通讯作者: Zivin, Justin A
DOI: 10.1097/00019052-200106000-00007
发表时间: 2001-06-01
影响因子: 4.8
作者:
Berger, J;Moser, HW;Forss-Petter, S
通讯作者: Forss-Petter, S
DOI: 10.1177/1545968305284675
发表时间: 2006-03-01
影响因子: 4.2
作者:
Dobkin, BH;Curt, A;Guest, J
通讯作者: Guest, J
DOI: 10.1602/neurorx.2.3.495
发表时间: 2005-07-01
期刊: NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics
影响因子: --
作者:
Fleming, Sheila M;Fernagut, Pierre-Olivier;Chesselet, Marie-Francoise
通讯作者: Chesselet, Marie-Francoise